These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 35408597)

  • 1. Structural Insights into the Design of Synthetic Nanobody Libraries.
    Valdés-Tresanco MS; Molina-Zapata A; Pose AG; Moreno E
    Molecules; 2022 Mar; 27(7):. PubMed ID: 35408597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Easily Established and Multifunctional Synthetic Nanobody Libraries as Research Tools.
    Liu B; Yang D
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Useful Nanobodies by Phage Display of Immune Single Domain Libraries Derived from Camelid Heavy Chain Antibodies.
    Romao E; Morales-Yanez F; Hu Y; Crauwels M; De Pauw P; Hassanzadeh GG; Devoogdt N; Ackaert C; Vincke C; Muyldermans S
    Curr Pharm Des; 2016; 22(43):6500-6518. PubMed ID: 27669966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and Construction of a Synthetic Nanobody Library: Testing Its Potential with a Single Selection Round Strategy.
    Contreras MA; Serrano-Rivero Y; González-Pose A; Salazar-Uribe J; Rubio-Carrasquilla M; Soares-Alves M; Parra NC; Camacho-Casanova F; Sánchez-Ramos O; Moreno E
    Molecules; 2023 Apr; 28(9):. PubMed ID: 37175117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Nanobody Scaffold Optimized for Bacterial Expression and Suitable for the Construction of Ribosome Display Libraries.
    Ferrari D; Garrapa V; Locatelli M; Bolchi A
    Mol Biotechnol; 2020 Jan; 62(1):43-55. PubMed ID: 31720928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Advances in nanobody screening technology].
    Tang X; Deng A; Chen W; Zhao Y; Wang M; Li C
    Sheng Wu Gong Cheng Xue Bao; 2024 Feb; 40(2):350-366. PubMed ID: 38369826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanobodies as efficient drug-carriers: Progress and trends in chemotherapy.
    Panikar SS; Banu N; Haramati J; Del Toro-Arreola S; Riera Leal A; Salas P
    J Control Release; 2021 Jun; 334():389-412. PubMed ID: 33964364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application Progress of the Single Domain Antibody in Medicine.
    Tang H; Gao Y; Han J
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in the selection and identification of antigen-specific nanobodies.
    Liu W; Song H; Chen Q; Yu J; Xian M; Nian R; Feng D
    Mol Immunol; 2018 Apr; 96():37-47. PubMed ID: 29477934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction and validation of a synthetic phage-displayed nanobody library.
    Kim M; Bai X; Im H; Yang J; Kim Y; Kim MM; Oh Y; Jeon Y; Kwon H; Lee S; Lee CH
    Korean J Physiol Pharmacol; 2024 Sep; 28(5):457-467. PubMed ID: 39198226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Two-Step Approach for the Design and Generation of Nanobodies.
    Wagner HJ; Wehrle S; Weiss E; Cavallari M; Weber W
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30400198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applications of Nanobodies.
    Muyldermans S
    Annu Rev Anim Biosci; 2021 Feb; 9():401-421. PubMed ID: 33233943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microcystin-LR nanobody screening from an alpaca phage display nanobody library and its expression and application.
    Xu C; Yang Y; Liu L; Li J; Liu X; Zhang X; Liu Y; Zhang C; Liu X
    Ecotoxicol Environ Saf; 2018 Apr; 151():220-227. PubMed ID: 29353171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selecting Nanobodies Specific for the Epidermal Growth Factor from a Synthetic Nanobody Library.
    Serrano-Rivero Y; Salazar-Uribe J; Rubio-Carrasquilla M; Camacho-Casanova F; Sánchez-Ramos O; González-Pose A; Moreno E
    Molecules; 2023 May; 28(10):. PubMed ID: 37241784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive charge in the complementarity-determining regions of synthetic nanobody prevents aggregation.
    Zhong Z; Yang Y; Chen X; Han Z; Zhou J; Li B; He X
    Biochem Biophys Res Commun; 2021 Oct; 572():1-6. PubMed ID: 34332323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Progress in nanobody and its application in diagnosis].
    Kong Q; Yao Y; Chen R; Lu S
    Sheng Wu Gong Cheng Xue Bao; 2014 Sep; 30(9):1351-61. PubMed ID: 25720150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection of Functional Intracellular Nanobodies.
    Woods J
    SLAS Discov; 2019 Aug; 24(7):703-713. PubMed ID: 31173539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development, Screening, and Validation of Camelid-Derived Nanobodies for Neuroscience Research.
    Gavira-O'Neill CE; Dong JX; Trimmer JS
    Curr Protoc Neurosci; 2020 Dec; 94(1):e107. PubMed ID: 33185319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanobody(R)-based chromatin immunoprecipitation/micro-array analysis for genome-wide identification of transcription factor DNA binding sites.
    Nguyen-Duc T; Peeters E; Muyldermans S; Charlier D; Hassanzadeh-Ghassabeh G
    Nucleic Acids Res; 2013 Mar; 41(5):e59. PubMed ID: 23275538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NanoLAS: a comprehensive nanobody database with data integration, consolidation and application.
    Xiong S; Liu Z; Yi X; Liu K; Huang B; Wang X
    Database (Oxford); 2024 Jan; 2024():. PubMed ID: 38300518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.